权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Filoviral glycoprotein/cellular protein interactions

丝状病毒糖蛋白/细胞蛋白相互作用

基本信息

批准号：
8645588
负责人：
Wendy Jean Maury
金额：
$ 37.2万
依托单位：
UNIVERSITY OF IOWA
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-05-18 至 2015-10-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8645588
关键词：
Africa Antibodies Antigens Antiviral Agents Antiviral Therapy Apical Autopsy Binding Bioinformatics Body Weight decreased CD4 Positive T Lymphocytes Categories Cell Line Cell Surface Receptors Cell surface Cells Comparative Genomic Analysis Complement Cytoplasmic Tail Democratic Republic of the Congo Development Disease Outbreaks Drug or chemical Tissue Distribution Ebola virus Ectopic Expression Endothelial Cells Epithelial Cells Epithelium Family member Filovirus Frankfurt-Marburg Syndrome Virus Future Galactosidase Genes Glycoproteins Helper-Inducer T-Lymphocyte Human Immunoglobulins Immunohistochemistry In Situ Hybridization Infection Iowa Kidney Knock-in Mouse Knock-out Knockout Mice Knowledge Lead Masks Mediating Membrane Proteins Morbidity - disease rate Mucin 1 protein Mucins Mus Pathogenesis Pattern Population Proteins Reporting Respiratory System Respiratory tract structure Role Structure of respiratory epithelium Surface T-Lymphocyte Testing Tissues Tyrosine United States National Institutes of Health Universities Vaccines Viral Hemorrhagic Fevers Viremia Virus Virus Diseases Virus-Cell Membrane Interaction Zoonotic Infection base biodefense design hepatoma cell in vivo mortality mouse model novel public health relevance receptor receptor binding screening transduction efficiency transmission process uptake virus pathogenesis

项目摘要

DESCRIPTION (provided by applicant): The filoviruses Ebola (EBOV) virus and Marburg (MARV) virus are responsible for devastating hemorrhagic fever outbreaks. No vaccines or therapies are currently available against these agents. Because of the high morbidity and mortality associated with infection, these zoonotic viruses have been placed on the NIH Biodefense Category A list. A cellular receptor that binds to and mediates filovirus uptake has not been identified. Identification of such a receptor and elucidation of filoviral glycoprotein (GP)/receptor interactions will facilitate the development of antivirals and enhance knowledge of filoviral pathogenesis. This submission is designed to help fill this knowledge gap. We have identified that the surface protein TIM-1 serves as a cellular receptor for filoviruses on epithelial cells. These studies will elucidate the interactions between human and murine TIM-1 and filovirus glycoproteins that are required for binding and virus entry into endothelial cells. Additionally, our studies to date demonstrated that the expression of TIM-1 within the body is poorly understood. In tissue sections, we will identify cells that express TIM-1 hypothesizing that TIM-1 expression is common on many epithelia. Finally, using a tim-1 knock out mouse, we will determine the impact of Tim-1 on EBOV infection and pathogenesis in the mouse model. In total, these studies will pave the way for the development of future antivirals against these deadly viruses.

描述（由申请方提供）：丝状病毒埃博拉（EBOV）病毒和马尔堡（MARV）病毒是造成毁灭性出血热暴发的原因。目前还没有针对这些病原体的疫苗或疗法。由于与感染相关的高发病率和死亡率，这些人畜共患病病毒已被列入NIH生物防御A类名单。尚未鉴定出结合并介导丝状病毒摄取的细胞受体。这种受体的鉴定和丝状病毒糖蛋白（GP）/受体相互作用的阐明将促进抗病毒药物的开发，并提高丝状病毒发病机制的知识。本次提交旨在帮助填补这一知识空白。我们已经确定，表面蛋白TIM-1作为上皮细胞上的丝状病毒的细胞受体。这些研究将阐明人和鼠TIM-1与丝状病毒糖蛋白之间的相互作用，这些糖蛋白是结合和病毒进入内皮细胞所必需的。此外，我们迄今为止的研究表明，TIM-1在体内的表达知之甚少。在组织切片中，我们将鉴定表达TIM-1的细胞，假设TIM-1表达在许多上皮细胞上是常见的。最后，使用Tim-1基因敲除小鼠，我们将确定Tim-1对小鼠模型中EBOV感染和发病机制的影响。总的来说，这些研究将为未来针对这些致命病毒的抗病毒药物的开发铺平道路。